Stockscreener 앱 받기
12.29
4.06%
0.48
시간 외 거래:
12.29
전일 마감가:
$11.81
열려 있는:
$12.03
하루 거래량:
459.07K
Relative Volume:
2.77
시가총액:
$1.57B
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-7.45%
1개월 성능:
+0.00%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$11.80
$12.43
1주일 범위
$11.53
$13.70
52주 변동 폭
$11.00
$13.95
Generate Biomedicines Inc Stock (GENB) Company Profile
Compare GENB vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GENB
Generate Biomedicines Inc
|
12.29 | 1.51B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Generate Biomedicines Inc 주식(GENB)의 최신 뉴스
Generate Biomedicines (GENB) Stock Trends and Sentiment 2026 - MarketBeat
Flagship-backed Generate Bio seeks $425 million in US IPO - MSN
Book value per share of Generate Biomedicines, Inc. – NASDAQ:GENB - TradingView
Generate Biomedicines (GENB) 10K Form and SEC Filings 2026 - MarketBeat
Pretax income of Generate Biomedicines, Inc. – NASDAQ:GENB - TradingView
Generate Biomedicines, Inc. Income Statement – NASDAQ:GENB - TradingView
Tangible book value per share of Generate Biomedicines, Inc. – NASDAQ:GENB - TradingView
Cash from investing activities of Generate Biomedicines, Inc. – NASDAQ:GENB - TradingView
Generate Biomedicines, Inc. Cash Flow – NASDAQ:GENB - TradingView
Enterprise value to EBITDA ratio of Generate Biomedicines, Inc. – NASDAQ:GENB - TradingView
GENB News Today | Why did Generate Biomedicines stock go down today? - MarketBeat
Working capital per share of Generate Biomedicines, Inc. – NASDAQ:GENB - TradingView
Generate Biomedicines (GENB) Stock Price, News & Analysis - MarketBeat
Generate Biomedicines (NASDAQ:GENB) Upgraded by Wall Street Zen to "Hold" Rating - MarketBeat
Return on assets % of Generate Biomedicines, Inc. – NASDAQ:GENB - TradingView
Price to cash flow ratio of Generate Biomedicines, Inc. – NASDAQ:GENB - TradingView
Generate Biomedicines (NASDAQ: GENB) holder reports 1.56M-share stake - Stock Titan
Fpn Ii, L.p. Net Worth (2026) - GuruFocus
Generate Biomedicines (GENB) Stock Chart and Price History 2026 - MarketBeat
Goodwin Advises Generate Biomedicines, Inc. On The Closing Of Its $400 Million Initial Public Offering - Mondaq
GENB Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
GENB Technical Analysis & Stock Price Forecast - Intellectia AI
Diluted net income available to common stockholders of Generate Biomedicines, Inc. – NASDAQ:GENB - TradingView
Dilution adjustment of Generate Biomedicines, Inc. – NASDAQ:GENB - TradingView
Generate Biomedicines (GENB) Valuation Check After Recent Share Price Weakness - Yahoo Finance
Generate Biomedicines Inc. (GENB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Generate Biomedicines IPO Opens Nasdaq Chapter And Investor Watch Period - simplywall.st
Generate Biomedicines, Inc. Cash Flow – BOATS:GENB - TradingView
Diluted shares outstanding of Generate Biomedicines, Inc. – BOATS:GENB - TradingView
Generate Biomedicines, Inc. Earnings and Revenue – BOATS:GENB - TradingView
Generate Biomedicines, Inc. Statistics – BOATS:GENB - TradingView
Generate Biomedicines, Inc. Income Statement – BOATS:GENB - TradingView
Generate Biomedicines, Inc. Revenue Breakdown – BOATS:GENB - TradingView
Generate Biomedicines, Inc. (GENB) Stock Live Price, Chart & News - CoinCodex
GENB PE Ratio & Valuation, Is GENB Overvalued - Intellectia AI
GENB | Generate Biomedicines, Inc. Common Institutional Ownership - Quiver Quantitative
GENB | Generate Biomedicines, Inc. Common Insider Trading - Quiver Quantitative
Insider Buying: Jane Mendillo Acquires Shares in Generate Biomed - GuruFocus
GENB: Static price chart | Generate Biomedicines, Inc. | US3709201004 - marketscreener.com
Assessing Generate Biomedicines (GENB) Valuation After Recent Share Price Volatility - simplywall.st
Generate Biomedicines amends charter and bylaws ahead of Nasdaq IPO By Investing.com - Investing.com UK
Executive at Generate Biomedicines (GENB) awarded 190,034 stock options - Stock Titan
Generate Biomedicines (GENB) CEO adds options and IPO conversion shares - Stock Titan
Director at Generate Biomedicines (GENB) buys stock and receives 29,561 options - Stock Titan
Director at Generate Biomedicines (GENB) awarded 29,561-share stock option grant - Stock Titan
Generate Biomedicines amends charter and bylaws ahead of Nasdaq IPO - Investing.com
Flagship funds boost Generate Biomedicines (GENB) stake with IPO conversions, buys - Stock Titan
Governance revamp at Generate Biomedicines (NASDAQ: GENB) after IPO - Stock Titan
Generate Biomedicines, Inc.Common Stock (Nasdaq:GENB) Stock Quote - FinancialContent
Generate Biomedicines’ IPO Brings In $400M for Pivotal Tests of Severe Asthma Drug - Dealbreaker
Generate IPO raises $400 million but shares sink - The Pharma Letter
Generate Biomedicines Inc (GENB) 재무 분석
Generate Biomedicines Inc (GENB)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):